Home › Employers › Covant Therapeutics Operating Inc.
Covant Therapeutics Operating Inc.: H-1B salaries and sponsorship
Covant Therapeutics Operating Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $157,400.
Does Covant Therapeutics Operating Inc. sponsor H-1B visas?
Covant Therapeutics Operating Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Nov 6, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Investigator, Biology | 1 | $164,800 |
| Senior Investigator, Proteomics Platform | 1 | $150,000 |
| Senior Director, Drug Product | 1 | — |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 1 | $164,800 |
| FY2025 | 1 | $150,000 |
| FY2026 | 1 | — |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Senior Director, Drug Product | $260,000 part-time · Level IV | New Hill, NC | Nov 6, 2025 | Nov 24, 2025 | Certified |
| Senior Investigator, Proteomics Platform | $150,000 Level II | Boston, MA | Jul 13, 2023 | Jul 15, 2023 | Certified, then withdrawn |
| Senior Investigator, Biology | $164,800 Level II | Boston, MA | May 1, 2023 | May 1, 2023 | Certified, then withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).